CAR NK therapy: An experimental immunotherapy treatment for blood cancers

Natural killer cells – or NK cells – are part of our immune system. They patrol the body looking for and destroying cells that can make us sick, such as cancer. But sometimes, cancer cells make themselves invisible, so the NK cells can’t do their job.

Katy Rezvani, M.D., Ph.D., has led a team to test an experimental cancer treatment called CAR NK therapy that enhances the cancer-fighting potential of NK cells. Through the first CAR NK therapy clinical trial, Rezvani is treating patients with chronic lymphocytic leukemia, non-Hodgkin lymphoma and acute lymphoblastic leukemia.

Watch to learn from Rezvani how CAR NK therapy works and what’s next with this clinical trial research.

Learn more: https://www.mdanderson.org/publicatio...

Request an appointment at MD Anderson by calling 1-877-632-6789 or by completing our online self-referral form: https://my.mdanderson.org/RequestAppo...